FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of cancer. A pharmaceutical composition for the treatment of cancer is proposed, containing effective amount of a purified bacterial mixture consisting of bacterial strains containing 16S of rDNA sequence at least 99% identical to a sequence SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10 and SEQ ID NO: 11. A pharmaceutical composition for the treatment of cancer is also proposed, additionally containing a pH-sensitive composition containing one or several intestinal soluble polymers.
EFFECT: group of inventions activates the immune system by inducing interferon-gamma-producing CD8+ T-cells.
30 cl, 57 dwg, 4 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR IMPROVING BLOCKADE THERAPY OF IMMUNE CHECKPOINTS THROUGH MICROBIOME MODULATION | 2017 |
|
RU2793582C2 |
| COMPOSITIONS AND METHODS | 2014 |
|
RU2664479C2 |
| VACCINE, SET AND TREATMENT AND PREVENTION METHOD OF ANIMALS-COMPANIONS' PARADONTOSIS | 2005 |
|
RU2364417C2 |
| ENDOPHYTE MICROBIAL SYMBIONS IN PRENATAL PLANT CARE | 2013 |
|
RU2723946C2 |
| COMPOSITION OF ANTIGEN-MHC NANOPARTICLES FOR INDUCING AN ANTI-INFLAMMATORY RESPONSE IN THE INTESTINE AND A METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2689563C2 |
| TRIPTAMIN METABOLISM MANIPULATION | 2018 |
|
RU2794244C2 |
| MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC EPITOPES OF CIRCUMSPOROZOITE PROTEIN PLASMODIUM | 2010 |
|
RU2585228C2 |
| METHOD FOR SELECTION OF MICROORGANISMS TO COMBINE IN COMPOSITION WITH CARRIERS | 2019 |
|
RU2793460C2 |
| HUMAN NECTIN-2 SPECIFIC ANTIBODIES | 2020 |
|
RU2820275C2 |
| STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS AND THEIR USE | 2018 |
|
RU2795545C2 |
